Significantly, the factors determining the remarkable efficacy of ICIs may include but are not limited to T cell intratumoral distribution, expression of PD-1/PD-L1, tumor antigenicity, and fitness of tumor-infiltrating T cells (127). This evidence concerns the gene CD274 and neoplasm.